Rejuvenate biomed, the nihr leicester brc, and wellcome leap partner for phase 2 study in copd-related sarcopenia

The phase 2 double-blin d placebo-controlled clinical trial will evaluate the potential of rjx-01 to maintain muscle integrity in older persons with severe acute exacerbation of copd
BRCC Ratings Summary
BRCC Quant Ranking